Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date Sort ascending | Activity Code(s) | Title |
|---|---|---|---|
| PA-21-221 | January 8, 2025 | R03 | NICHD Small Research Grant Program (R03 Clinical Trial Required) |
| PAR-21-115 | January 8, 2025 | R01 | Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
| PA-20-196 | January 8, 2025 | R21 | NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) |
| NOT-HL-22-025 | January 8, 2025 | R01 | Notice of Special Interest (NOSI): Respiratory Complications of the Muscular Dystrophies (R01) |
| NOT-HD-22-038 | January 8, 2025 | R15,R03,R01,R21 | Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NICHD Populations of Interest |
| PAR-22-098 | December 10, 2024 | R21 | Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) |
| PAR-22-097 | December 10, 2024 | R01 | Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) |
| PAR-23-180 | December 8, 2024 | R01 | Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
| PAR-22-222 | December 8, 2024 | R01 | Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
| RFA-NS-22-034 | December 7, 2024 | R01 | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) |
| NOT-OD-22-135 | November 29, 2024 | R01,333,R21,K01,R34,R33,R61/R33,UG3/UH3,K43 | Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity |
| PAR-24-045 | November 20, 2024 | R21 | Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
| PAR-24-046 | November 20, 2024 | R21 | Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
| PAR-21-354 | November 17, 2024 | R03 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) |
| PAR-22-236 | November 17, 2024 | R21 | Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed) |
| PAR-21-355 | November 17, 2024 | R21 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
| NOT-OD-22-124 | November 13, 2024 | K99/R00,K23,K08,K01,K43,UE5 | Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project |
| PAR-22-237 | November 6, 2024 | R01 | Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R01 Clinical Trial Not Allowed) |
| PAR-21-353 | November 6, 2024 | R01 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
| PAR-22-101 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
BACK TO TOP